Refine your search
Availability
-
Authors
-
Topics
- Biomarkers
- C-Reactive Protein
- Cardiovascular Diseases
- Cost-Benefit Analysis
- Diagnosis-Related Groups
- Drug Approval
- Fluorobenzenes
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hypercholesterolemia
- Markov Chains
- Models, Statistical
- Primary Prevention
- Pyrimidines
- Risk Assessment
- Rosuvastatin Calcium
- Sulfonamides
- United States
- United States Food and Drug Administration
- drug effects
- Show more
- Show less
-
Languages